UK clinical practice guidelines for the management of patients with constitutional <i>POT1</i> pathogenic variants
Olga Tsoulaki(St George's, University of London), Helen Hanson(University of Exeter), Claire Forde(Manchester University NHS Foundation Trust), Emma R. Woodward(Royal Manchester Children's Hospital), Sunil Iyengar(Royal Marsden Hospital), Aslam Sohaib(Royal Marsden Hospital), Marc Tischkowitz(University of Cambridge), Neil Rajan(Royal Victoria Infirmary), Terri McVeigh(Royal Marsden Hospital), Helen Hatcher(Addenbrooke's Hospital), Fiona Lalloo(Manchester Academic Health Science Centre), Andrea Napolitano(National Health Service), Farah Bakr(St Thomas' Hospital), D Gareth Evans(University of Manchester)
Cited by 8
Related Papers
Founder and Recurrent CDH1 Mutations in Families With Hereditary Diffuse Gastric Cancer
|JAMA|2007|455
Germline-focussed analysis of tumour-only sequencing: recommendations from the ESMO Precision Medicine Working Group
|Annals of Oncology|2019|237
Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients
|Scientific Reports|2016|224
<i>PALB2</i>, <i>CHEK2</i> and <i>ATM</i> rare variants and cancer risk: data from COGS
|Journal of Medical Genetics|2016|217
Clinical practice guidelines for BRCA1 and BRCA2 genetic testing
|European Journal of Cancer|2021|174